Reduced-antigen combined diphtheria-tetanus-acellular pertussis vaccine (Boostri™) -: Guest commentary

被引：0
|
作者：
Van der Wielen, M [1 ]
Theeten, H [1 ]
机构：
[1] Univ Instelling Antwerp, Ctr Evaluat Vaccinat, B-2610 Wilrijk, Belgium
来源：
DRUGS | 2003年 / 63卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1415 / 1416
页数：2
相关论文
共 50 条
  • [31] Repeated administration of a reduced-antigen-content diphtheria-tetanus-acellular pertussis and poliomyelitis vaccine (dTpa-IPV; Boostrix™ IPV)
    Knuf, Markus
    Vetter, Volker
    Celzo, Froilan
    Ramakrishnan, Gunasekaran
    Van der Meeren, Olivier
    Jacquet, Jeanne M.
    HUMAN VACCINES, 2010, 6 (07): : 554 - 561
  • [32] Booster vaccination against pertussis in Chinese children at six years of age using reduced antigen content diphtheria-tetanus-acellular pertussis vaccine (Boostrix™)
    Zhu, Fengcai
    Zhang, Shumin
    Hou, Qiming
    Zhang, Yiju
    Xu, Yinghua
    Ma, Xiao
    Lu, Xidong
    Pan, Hongxing
    Chen, Dengfeng
    Ramakrishnan, Gunasekaran
    Zhao, Richard
    Tang, Haiwen
    Van der Meeren, Olivier
    Bock, Hans L.
    HUMAN VACCINES, 2010, 6 (03): : 263 - 269
  • [33] Safety of a 5TH Dose of a Diphtheria-Tetanus-Acellular Pertussis Vaccine(Tripedia®)
    Edward P Rothstein
    Loretta Wubbel
    Keh-Wei Chen
    Pediatric Research, 1999, 45 : 173 - 173
  • [34] Evaluation of a new syringe presentation of reduced-antigen content diphtheria, tetanus, and acellular pertussis vaccine in healthy adolescents - A single blind randomized trial
    Pavia-Ruz, Noris
    Abarca, Katia
    Lepetic, Alejandro
    Yolanda Cervantes-Apolinar, Maria
    Hardt, Karin
    Jayadeva, Girish
    Kuriyakose, Sherine
    Han, Htay Htay
    de la O, Manuel
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (07) : 1770 - 1774
  • [35] Safety of a 5TH dose of a diphtheria-tetanus-acellular pertussis vaccine (Tripedia®)
    Rothstein, EP
    Wubbel, L
    Chen, KW
    PEDIATRIC RESEARCH, 1999, 45 (04) : 173A - 173A
  • [36] Immunogenicity and safety of a tetravalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine
    Gyhrs, A
    Lyngholm, E
    Larsen, SO
    Aggerbeck, H
    Heron, I
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1999, 31 (06) : 579 - 585
  • [37] Interchangeability of 2 diphtheria-tetanus-acellular pertussis vaccines in infancy
    Greenberg, DP
    Pickering, LK
    Senders, SD
    Bissey, JD
    Howard, RA
    Blatter, MM
    Reisinger, K
    Pichichero, ME
    Howe, BJ
    PEDIATRICS, 2002, 109 (04) : 666 - 672
  • [38] A phase 2 study of a combined diphtheria-tetanus-acellular pertussis vaccine with a Sabin-derived inactivated poliovirus vaccine in children
    Nakano, Takashi
    Sumino, Shuji
    Takanami, Yohei
    Mitsuya, Nodoka
    Nakatome, Keisuke
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (12) : 2940 - 2949
  • [39] Collaborative study: Standardization of Japanese reference diphtheria and tetanus toxoids, (adsorbed, Lot 2), for potency determination of diphtheria-tetanus-acellular pertussis combined vaccine
    Iwaki, M
    Komiya, T
    Fukuda, T
    Arakawa, Y
    Takahashi, M
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2003, 56 (04) : 183 - 185
  • [40] Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents
    Pichichero, ME
    Blatter, MM
    Kennedy, WA
    Hedrick, J
    Descamps, D
    Friedland, LR
    PEDIATRICS, 2006, 117 (04) : 1084 - 1093
12345